Medication and Pharmacy Errors: Basics for Louisiana Patients

You picked up a prescription at a Lake Charles pharmacy on a Thursday afternoon, took it as directed, and woke up Friday unable to move your legs. The bottle had your name on it. The drug inside wasn't what your doctor ordered. Or it was the right drug at twice the prescribed dose. Or it interacted with something else in your medication profile that anyone who looked at the screen should have caught. Something that was supposed to help you put you in the hospital instead.

Because Louisiana's 51% fault rule and two-year deadline can change how much you can recover, it helps to understand the basics. Read our explainer on the 51% fault rule and two-year deadline in Louisiana.

Louisiana Civil Code Article 2315 gives patients the right to pursue compensation when a healthcare provider's negligence causes harm, and medication errors fall squarely within that framework. Whether the error happened in a hospital, a clinic, or a retail pharmacy on Ryan Street changes which procedural rules apply — the Medical Malpractice Act at LA R.S. 40:1231.1 governs claims against enrolled providers, while the Louisiana Pharmacy Practice Act at LA R.S. 37:1182 and general negligence principles govern many retail pharmacy claims. The one-year prescriptive period and Louisiana's modified comparative fault rule under CC Art. 2323 apply in both settings.

What Counts as a Medication Error

The National Coordinating Council for Medication Error Reporting and Prevention defines a medication error as any preventable event that may cause or lead to inappropriate medication use or patient harm. For legal purposes in Louisiana, the operative question is narrower: did a healthcare provider's departure from the accepted standard of care cause the patient measurable harm?

Wrong-drug errors occur when the patient receives a different medication than was prescribed — sometimes because of look-alike or sound-alike drug names, sometimes because of data entry errors, sometimes because a handwritten prescription was misread. Wrong-dose errors deliver the right drug at the wrong strength, either too high causing toxicity or too low failing to treat the condition. Wrong-patient errors are rarer but documented, particularly in hospital inpatient settings where multiple patients are managed simultaneously.

Failure-to-warn errors are their own category. A pharmacist who fills a prescription without flagging a dangerous interaction with another drug in the patient's profile, when the interaction was identifiable from the patient's medication history in the pharmacy system, has failed the standard of care even if the individual prescription was filled correctly. Louisiana Pharmacy Practice Act standards (LA R.S. 37:1182) require pharmacists to perform a prospective drug review — checking the patient's medication record for interactions — before dispensing.

Prescribing errors by physicians are a separate but related category: wrong drug for the diagnosis, wrong dose for the patient's weight or renal function, prescribing a drug the patient's chart showed they were allergic to. These claims follow the Medical Malpractice Act process for qualified providers.

Key Takeaway: Medication errors include wrong drug, wrong dose, wrong patient, and failure to identify dangerous drug interactions. Each type can support a Louisiana negligence or malpractice claim, but the procedural path — MMA with Review Panel, or direct court filing — depends on whether the provider is enrolled in the Patient Compensation Fund.

Who Can Be Held Responsible

Multiple parties can bear liability for the same medication error, and identifying all of them is one of the first things a malpractice attorney does in these cases.

We explain how fault percentages and deadlines work after a Louisiana injury in our 2026 Tort Reform Survival Guide.

The prescribing physician is responsible for the accuracy and completeness of the prescription — the right drug for the diagnosis, the right dose for the patient, and the right instructions for administration. Prescribing a drug the patient's chart shows they're allergic to, or prescribing a dose that doesn't account for the patient's kidney disease or body weight, are physician-level errors.

The pharmacist is responsible for verifying the prescription as written, checking the patient's medication profile for interactions, filling the prescription accurately, and counseling the patient on proper use. These duties are codified in the Louisiana Pharmacy Practice Act. A pharmacist who fills a prescription without checking the profile, or who dispenses the wrong drug from adjacent shelves, has deviated from the standard of care.

In hospital settings, nurses who administer medications carry their own duty: verifying the right patient, right drug, right dose, right route, and right time before administration (the "five rights" of medication administration). A nurse who fails that verification and gives one patient another patient's medication has made a nursing error, and the hospital faces respondeat superior liability for that employee's act.

The pharmacy corporation itself — not just the individual pharmacist — can be a defendant when the error results from understaffing, inadequate training, system design failures, or a corporate policy of overriding safety alerts to meet prescription volume targets.

MMA vs. General Negligence: Which Path Applies

This distinction matters significantly for how the case proceeds and what damages are available.

Claims against qualified healthcare providers enrolled in the Patient Compensation Fund are governed by the Medical Malpractice Act (LA R.S. 40:1231.1). That means: mandatory Medical Review Panel before filing suit, one-year prescriptive period with tolling during the panel process, $500,000 cap on general damages with future medical paid separately by the Fund, and the panel opinion admissible at trial. Hospital pharmacists employed by a MMA-qualified facility are typically covered. Prescribing physicians at qualified practices are covered.

Claims against retail pharmacies and pharmacists not enrolled in the PCF are not governed by the MMA. No Review Panel is required. No $500,000 damages cap applies. The patient files directly in district court under Louisiana's general negligence framework. The one-year prescriptive period from discovery still applies (CCP Art. 3492), but there is no tolling mechanism tied to a panel request. This is often a faster and potentially higher-value path for retail pharmacy error claims.

Checking whether a given pharmacy or pharmacist is enrolled in the PCF is one of the first steps in evaluating a medication error claim. Larger chain pharmacies in the Lake Charles area often are not enrolled, which means direct court filing, no cap, and no mandatory panel wait.

Key Takeaway: Whether the MMA applies to a medication error claim depends on whether the provider is enrolled in the Patient Compensation Fund. Retail pharmacies are often not enrolled — meaning no Review Panel, no damages cap, and direct court filing. Hospital pharmacists and prescribing physicians at qualified practices typically are enrolled.

How Comparative Fault Applies to Medication Error Claims

Louisiana's modified comparative fault rule under CC Art. 2323 gives defense teams room to argue the patient contributed to the harm. Common arguments in medication error cases: the patient didn't tell their prescriber about other medications they were taking; the patient continued taking a drug after experiencing symptoms that should have prompted a call to the physician; the patient took a medication incorrectly despite clear labeling instructions.

Run the math on a specific case. A patient at a Lake Charles pharmacy receives the wrong anticoagulant dose — twice the prescribed strength. They experience a serious gastrointestinal bleed requiring hospitalization. Damages are valued at $280,000. The defense argues the patient had been told by a prior physician to follow a low-dose aspirin regimen and failed to disclose that to the current prescriber, and that the aspirin combined with the high-dose anticoagulant increased the bleeding risk. The jury assigns 20% fault to the patient. Recovery drops from $280,000 to $224,000. That 20% finding cost the patient $56,000.

At 51% patient fault, no recovery at all. Always tell your prescribers about every medication you're taking, including over-the-counter drugs, supplements, and anything prescribed by a different provider. That disclosure is your single strongest protection against a comparative fault argument in a medication interaction case.

Key Takeaway: Comparative fault arguments in medication error cases focus on undisclosed medications and failure to follow instructions. Full disclosure to every prescriber of every drug you're taking — prescription and over-the-counter — is the best protection against a fault percentage that reduces your recovery.
For a full overview of how the 2026 tort reform affects your rights and timelines, read our Louisiana Tort Reform Survival Guide.

Frequently Asked Questions

What is a medication error under Louisiana law?

A medication error is any preventable event involving a wrong drug, wrong dose, wrong patient, wrong route of administration, or a failure to identify a dangerous drug interaction, where a provider's departure from the standard of care caused patient harm. Louisiana Civil Code Article 2315 provides the tort authority. Whether the claim goes through the Medical Malpractice Act's Review Panel process depends on whether the responsible provider is enrolled in the Patient Compensation Fund. Retail pharmacy errors often fall outside the MMA entirely, allowing direct court filing with no damages cap.

Does the Louisiana Medical Malpractice Act cover pharmacy errors?

It covers pharmacy errors when the pharmacist or pharmacy is a qualified healthcare provider enrolled in the PCF. Hospital pharmacists employed by qualified facilities typically are covered. Many retail pharmacies and their pharmacists are not enrolled, which means claims against them bypass the Review Panel requirement, are not subject to the $500,000 cap, and are filed directly in district court. Checking PCF enrollment status is one of the first steps in evaluating any medication error claim in Louisiana.

How long do I have to file a medication error claim in Louisiana?

For MMA-covered providers, one year from discovery of the error, with a three-year absolute outer limit from the date of the act (LA R.S. 40:1231.8). Filing a Medical Review Panel request stops the clock. For retail pharmacies outside the MMA, the general one-year prescriptive period from discovery applies under CCP Art. 3492, with no panel-request tolling mechanism. In both settings, acting promptly after discovering the error protects the claim and makes evidence collection easier while records and memories are current.

Can I sue a retail pharmacy for a prescription error in Louisiana?

Yes. Retail pharmacies and individual pharmacists owe patients a duty of care under Louisiana Civil Code Article 2315 and the Louisiana Pharmacy Practice Act (LA R.S. 37:1182), which requires pharmacists to perform a prospective drug review and counsel patients before dispensing. When a pharmacy dispenses the wrong drug or fails to flag a known drug interaction from the patient's profile, both the pharmacy corporation and the individual pharmacist can be named as defendants. For retail pharmacies not enrolled in the PCF, there is no cap on recoverable damages.

What types of harm can result from a medication error?

Wrong-drug errors can cause allergic reactions, organ failure, or death when a patient receives a medication their system cannot tolerate. Overdoses cause toxicity events ranging from serious illness to cardiac arrest. Underdoses of critical drugs — antibiotics failing to treat an infection, anticoagulants failing to prevent a clot — allow the underlying condition to progress and cause harm that proper dosing would have prevented. Drug interaction failures cause unpredictable and sometimes catastrophic cardiovascular, neurological, or bleeding events. Louisiana law allows recovery for all of these through a properly filed claim against the responsible provider.

Legal Disclaimer: This article is for general information only and is not legal advice. Louisiana medication error and medical malpractice law has a lot of moving parts, and the facts of every case are different. Statutes, regulations, and case law also change over time. Reading this does not create an attorney-client relationship. If you were harmed by a medication or pharmacy error in Lake Charles or Calcasieu Parish, talk to a licensed Louisiana personal injury attorney as soon as you can. The one-year prescriptive period for personal injury claims is strictly enforced.

Sources & Citations:
  • Louisiana Civil Code Article 2315 — General tort liability
  • Louisiana Civil Code Article 2323 — Modified comparative fault (51% bar, effective 2026)
  • Louisiana Code of Civil Procedure Article 3492 — One-year prescriptive period for personal injury
  • Louisiana Revised Statutes 40:1231.1 — Louisiana Medical Malpractice Act
  • Louisiana Revised Statutes 40:1231.2 — Medical Review Panel procedure
  • Louisiana Revised Statutes 40:1231.8 — Patient Compensation Fund; prescriptive periods
  • Louisiana Revised Statutes 37:1182 — Louisiana Pharmacy Practice Act; pharmacist duties and standards
Author
INJURY GUIDE CURATOR

admin

Dedicated to compiling clear, accessible documentation and local resource guides to help Lake Charles residents navigate post-injury recovery.

Need Specific Legal Advice?

Connect with a local professional who can evaluate your specific case.

Schedule a Free Consultation